scispace - formally typeset
Open AccessJournal Article

Familial transthyretin amyloidosis

Reads0
Chats0
TLDR
A case of familial transthyretin amyloidosis with TTR Cys 114 gene polymorphism is described, the first in Russia and third in the world.
Abstract
A case of familial transthyretin amyloidosis with TTR Cys 114 gene polymorphism is described (first in Russia and third in the world). The clinical picture of the proband was dominated by symptoms of autonomous polyneuropathy (orthostatic hypotension, erectile dysfunction, diarrhea, tachycardia, foot dyshydrosis) and of somatic nerve lesions (dumbness, impaired surface and deep sensitivity in the limbs). The patient presented with vitreous body opacity, disturbed eye movements, lateralized sensory symptoms, and difficulty of speech (baryphonia). Electromyographic quantitative autonomous testing and measurement of evoked sympathetic skin potentials confirmed affection of peripheral nerves. Heart ultrasound revealed restrictive amyloid cardiopathy. Histological analysis showed amyloid deposition in the intestines and sural nerve. The proband, his daughter, brother (monozygous twin), and brother's daughter had mutant TTR Cys 114 gene. The brother also had amyloid deposits in the absence of clinical signs of the disease. Analysis of familial medical history demonstrated autosomal dominant inheritance of this mutation in 4 generations. Its possible origin and clinical features of the disease are discussed.

read more

Citations
More filters
Journal ArticleDOI

Poor outcome after liver transplantation for transthyretin amyloid neuropathy in a family with an Ala36Pro transthyretin mutation: case report.

TL;DR: This work describes the cases of 2 siblings with transthyretin amyloid polyneuropathy secondary to an infrequently reported tran StHyretin mutation (Ala36Pro) who underwent liver transplantation with poor outcomes.
Journal ArticleDOI

Endoscopic Findings of Small-Bowel Lesions in Familial Amyloid Polyneuropathy: A Case Report

TL;DR: A 71-year-old woman complaining of refractory diarrhea for 1 year and analysis of the genomic DNA showed a heterozygous Gly47Val mutation in the transthyretin gene, a diagnosis of FAP was established.
Journal ArticleDOI

Doxycycline in ATTRY69H (p.ATTRY89H) amyloidosis with predominant leptomeningeal manifestation

TL;DR: In this patient, both the cognitive function and unsteadiness in walking improved notably in the very first months following the start of doxycycline treatment, already leading to safe and unaided walking for most of the time.
References
More filters
Journal ArticleDOI

First European consensus for diagnosis, management, and treatment of transthyretin familial amyloid polyneuropathy

TL;DR: Greater communication, not just between members of an individual patient's treatment team, but also between regional and national centres of expertise, is the key to the effective management of TTR-FAP.
Journal ArticleDOI

Cardiac amyloidosis: An update on diagnosis and treatment.

TL;DR: Cardiac amyloidosis (CA), once thought to be a rare disease, is increasingly recognized due to enhanced clinical awareness and better diagnostic imaging, and reversingAmyloid deposition in affected organs using monoclonal antibodies is actively being tested in clinical trials.
Journal ArticleDOI

Transthyretin: a multifaceted protein.

TL;DR: The aim of this review is to stress the relevance of TTR, besides its well-known role on transport of thyroxine and retinol-binding protein, in the nervous system, as well as in ischemia and Alzheimer’s disease.
Journal ArticleDOI

Diagnosis and management of transthyretin familial amyloid polyneuropathy in Japan: red-flag symptom clusters and treatment algorithm

TL;DR: A consolidated review of the ATTR-FAP Val30Met landscape in Japan is presented and findings are summarized from a medical advisory board meeting held in Tokyo on 18th August 2016, at which a Japan-specific ATTR -FAP red-flag symptom cluster and treatment algorithm was developed.
Journal ArticleDOI

Risk of transmission of systemic transthyretin amyloidosis after domino liver transplantation.

TL;DR: De novo systemic amyloidosis after DLT may be more frequent and appear earlier than was initially thought and the graft shortage still justifies DLT in selected patients, despite the risk of de novo systems amyloidsosis.
Related Papers (5)